Home -> Law Blog Directory -> Personal Injury Law Blogs -> Honolulu Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Honolulu Personal Injury LawyerReport indicates drug makers spent over $2.9 million on Vermont physicians to market products.
By Wayne Parsons
The AP (4/16, Curran) reports, "The nation's pharmaceutical makers spent more than $2.9 million on Vermont's doctors, hospitals and universities to market their products in the last fiscal year, according to a report issued Wednesday by the state attorney general's office." Attorney General William Sorrell noted, however, that the total is "down slightly from the previous year," but "he's not sure if the drug companies are tightening their belts or if they want to avoid public scrutiny for the payments, whose recipients aren't identified." Companies are required "by law...to report their spending on consulting and speakers' fees, travel expenses, gifts, and other payments to or for physicians, hospitals, universities, and others authorized to prescribe drugs." These disclosures "don't include money spent on advertising." The report indicates that "78 companies spent the money in the year ending July 1, 2008." Notably, "Eli Lilly and Co., Pfizer Inc., Novartis Pharmaceuticals Corp., Merck & Co. and Forest Pharmaceuticals Inc. were the biggest spenders." But, "more than 80 percent of the expenditures analyzed for the report claimed the trade secret designation," Sorrell noted.
Originally posted at InjuryBoard by Wayne ParsonsFull post as published by Honolulu Personal Injury Lawyer on April 16, 2009 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Truth In Lending Act
Consumer Loans and Consumer Credit Protection Act
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...
Bank Website Security
New Report Finds Widespread Flaws
Operating Room Fires
Hundreds Injured During Surgery, New Report Shows
Whole Foods Market Recalls Bulk Hazelnuts
Whole Foods Market Recalls Bulk Hazelnuts

Report Indicates Drugmakers Spent Over $2.9 Million on Vermont Physicians to Market Products
EU steps up antitrust investigation of drug makers.
Could Drugmakers Use Journals to Promote Off Label Use
FDA Review to Pre-Empt State Pharmaceutical Litigation
Punitive Damages Added to Peanut Lawsuit









